Biotech VCs ramp up checks on new bets after years of focusing on existing portfoliosnews2026-04-10T14:27:52+00:00April 10th, 2026|Endpoints News|
David Sinclair startup Life Biosciences raises $80M for clinical test of anti-aging gene therapynews2026-04-08T12:00:17+00:00April 8th, 2026|Endpoints News|
ADC biotech Sidewinder collects $137M for bispecific approachnews2026-04-08T11:00:04+00:00April 8th, 2026|Endpoints News|
European VC Jeito gets $1.2B to help private biotechs control their ‘destiny’news2026-04-08T07:16:52+00:00April 8th, 2026|Endpoints News|
Gilead continues dealmaking streak with $3.15B Tubulis buy for ADCsnews2026-04-07T12:17:00+00:00April 7th, 2026|Endpoints News|
Stipple Bio launches with $100M to find more precise targets on cancer proteinsnews2026-04-06T11:00:13+00:00April 6th, 2026|Endpoints News|
Aspect Biosystems gets $79M from Canadian government for diabetes cell therapynews2026-04-02T18:32:29+00:00April 2nd, 2026|Endpoints News|
Noom plans push into peptides beyond weight loss drugsnews2026-04-01T20:47:39+00:00April 1st, 2026|Endpoints News|
Paragon offshoot Korsana to go public in reverse merger for Alzheimer’s worknews2026-04-01T15:20:48+00:00April 1st, 2026|Endpoints News|
Pharma goes on $25.5B, eight-day acquisition spreenews2026-03-31T19:32:28+00:00March 31st, 2026|Endpoints News|
